Your browser doesn't support javascript.
loading
Real-World Response and Outcomes in Patients With NSCLC With EGFR Exon 20 Insertion Mutations.
Ou, Sai-Hong Ignatius; Lin, Huamao M; Hong, Jin-Liern; Yin, Yu; Jin, Shu; Lin, Jianchang; Mehta, Minal; Nguyen, Danny; Neal, Joel W.
Affiliation
  • Ou SI; Division of Hematology-Medical Oncology, Department of Internal Medicine, Chao Family Comprehensive Cancer Center, University of California Irvine School of Medicine, Orange, California.
  • Lin HM; Global Evidence and Outcomes Oncology, Takeda Development Center Americas, Inc., Lexington, Massachusetts.
  • Hong JL; Global Evidence and Outcomes Oncology, Takeda Development Center Americas, Inc., Lexington, Massachusetts.
  • Yin Y; Oncology Statistics, Takeda Pharmaceuticals United States, Inc., Lexington, Massachusetts.
  • Jin S; Clinical Science, Oncology, Takeda Development Center Americas, Inc., Lexington, Massachusetts.
  • Lin J; Oncology Statistics, Takeda Pharmaceuticals United States, Inc., Lexington, Massachusetts.
  • Mehta M; Clinical Science, Oncology, Takeda Development Center Americas, Inc., Lexington, Massachusetts.
  • Nguyen D; Oncology and Hematology, City of Hope National Medical Center, Duarte, California.
  • Neal JW; Division of Oncology, Department of Medicine, Stanford Cancer Institute, Stanford University, Stanford, California.
JTO Clin Res Rep ; 4(10): 100558, 2023 Oct.
Article in En | MEDLINE | ID: mdl-37744306
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: JTO Clin Res Rep Year: 2023 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: JTO Clin Res Rep Year: 2023 Document type: Article